Effect of Vergence Exercises for Patients With Convergence Insufficiency After Concussion.

Sponsor
Danish College of Optometry and Vision Science (Other)
Overall Status
Active, not recruiting
CT.gov ID
NCT05012384
Collaborator
(none)
100
1
2
23
4.3

Study Details

Study Description

Brief Summary

A large proportion of concussion patients with long-term consequences of concussion experience visually related symptoms such as headache, blurred vision, double vision, and fatigue.

These patients often have difficulties coordinating the movement of the two eyes (convergence insufficiency) which is essential for single and clear vision to be obtained and is hence a likely explanation for the symptoms.

100 patients with long-term symptoms of concussion and convergence insufficiency will be offered either exercises or placebo treatment the evaluate the effect of exercises aimed at improving coordination between the two eyes.

The study will provide data to support clinicians in deciding whether to use exercises or not as a treatment of symptoms for patients with convergence insufficiency as a long-term consequence of concussion.

Condition or Disease Intervention/Treatment Phase
  • Other: Vergence exercises (Orthoptic exercises)
  • Genetic: Placebo
N/A

Study Design

Study Type:
Interventional
Anticipated Enrollment :
100 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Intervention Model Description:
Randomized clinical trialRandomized clinical trial
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
Effect of Vergence Exercises for Rehabilitation of Patients With Convergence Insufficiency as a Long-term Consequence of Concussion.
Actual Study Start Date :
Jul 1, 2021
Anticipated Primary Completion Date :
Mar 1, 2023
Anticipated Study Completion Date :
Jun 1, 2023

Arms and Interventions

Arm Intervention/Treatment
Experimental: Vergence exercises

Orthoptic vergence exercises

Other: Vergence exercises (Orthoptic exercises)
Vergence exercises as described by the Convergence Insufficiency Treatment Trials Group (CITT)

Placebo Comparator: Generic treatment

Genetic: Placebo
Generic management plan with non-visual elements

Outcome Measures

Primary Outcome Measures

  1. Convergence Insufficiency Symptom Survey (CISS) week 18 [Duration (5 minutes) and performed at week 18]

    Questionnaire assessing the frequency of eye and visually related symptom during near work

  2. Convergence Insufficiency Symptom Survey (CISS) week 36 [Duration (5 minutes) and performed at week 36]

    Questionnaire assessing the frequency of eye and visually related symptom during near work

  3. Near point of convergence - week 18 [Duration (2 minutes) and performed at week 18]

    Psychophysical test of the eyes ability to converge

  4. Near point of convergence - week 36 [Duration (2 minutes) and performed at week 36]

    Psychophysical test of the eyes ability to converge

  5. Positive fusional vergence at 40 cm - week 18 [Duration (2 minutes) and performed at week 18]

    Psychophysical test of the slow fusional adaptation

  6. Positive fusional vergence at 40 cm - week 36 [Duration (2 minutes) and performed at week 36]

    Psychophysical test of the slow fusional adaptation

  7. Vergence facility at 40 cm - week 18 [Duration (2 minutes) and performed at week 18]

    Psychophysical test of fast fusional adaptation

  8. Vergence facility at 40 cm - week 36 [Duration (2 minutes) and performed at week 36]

    Psychophysical test of fast fusional adaptation

Secondary Outcome Measures

  1. Rivermead post-concussional symptoms questionnaire (RPQ) - week 18 [Duration (5 minutes) and performed at week 18]

    Questionnaire assessing the frequency of symptoms during activities of daily living

  2. Rivermead post-concussional symptoms questionnaire (RPQ) - week 36 [Duration (5 minutes) and performed at week 36]

    Questionnaire assessing the frequency of symptoms during activities of daily living

Eligibility Criteria

Criteria

Ages Eligible for Study:
30 Years to 60 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Concussion at least 3 month ago

  • Convergence insufficiency which has not been diagnosed prior to the concussion

Exclusion Criteria:
  • Patient who are unable to fulfill baseline examination

  • Manifest or paralytic strabismus

  • Self-reported eye disease

Contacts and Locations

Locations

Site City State Country Postal Code
1 Danish College of Optometry and Vision Science Randers Central Region, Denmark Denmark 8960

Sponsors and Collaborators

  • Danish College of Optometry and Vision Science

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Danish College of Optometry and Vision Science
ClinicalTrials.gov Identifier:
NCT05012384
Other Study ID Numbers:
  • 1-10-72-22-21
First Posted:
Aug 19, 2021
Last Update Posted:
Aug 19, 2021
Last Verified:
Jul 1, 2021
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Aug 19, 2021